IP Library › Granted Patent US 9,943,684
Granted Patent B2
US 9,943,684 · App. 14/869,286 · Granted Apr 17, 2018

Nanosecond pulsed electric fields cause melanomas to self-destruct

Inventors: Richard Nuccitelli (Norfolk, VA); Stephen J. Beebe (Norfolk, VA); Karl H. Schoenbach (Norfolk, VA)
Assignees: Eastern Virginia Medical School; Old Dominion University Research Foundation
A61N1/205A61N1/327
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,943,684
App. No.
14/869,286
Granted
Apr 17, 2018
Kind
B2
Abstract

Methods for a new, drug-free therapy for treating solid skin tumors through the application of nanosecond pulsed electric fields (“nsPEFs”) are provided. In one embodiment of the invention, the cells are melanoma cells, and the applied nsPEFs penetrate into the interior of tumor cells and cause tumor cell nuclei to rapidly shrink and tumor blood flow to stop. This new technique provides a highly localized targeting of tumor cells with only minor effects on overlying skin.

Claims (25)

1. A method for selectively initiating apoptosis in skin cells in a tissue comprising coating a skin tissue with a composition that reduces flashover during pulse field application; and applying at least 100 nsPEFs to said tissue, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 10 kV/cm and no more than about 350 kV/cm.

2. The method of claim 1 , whereby said method is carried out in situ.

3. The method of claim 1 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field pulse strength of at least about 20 kV/cm and no more than about 125 kV/cm.

4. The method of claim 1 , wherein said method is repeated one or more times.

5. A method for inhibiting blood flow in a tissue comprising skin cells the method comprising:

coating a skin tissue with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said skin tissue, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 10 kV/cm and no more than about 350 kV/cm.

6. The method of claim 5 , whereby said method is carried out in situ.

7. The method of claim 5 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field pulse strength of at least about 20 kV/cm and no more than about 40 kV/cm.

8. The method of claim 5 , wherein said method is repeated one or more times.

9. A method for inducing tumor regression in a tumor located in skin tissue comprising:

coating a skin tissue overlying the tumor with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said tumor, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 10 kV/cm and no more than about 350 kV/cm.

10. The method of claim 9 , whereby said method is carried out in situ.

11. The method of claim 9 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds and an electric field pulse strength of at least about 20 kV/cm and no more than about 40 kV/cm.

12. The method of claim 9 , wherein said method is repeated one or more times.

13. The method of claim 9 , wherein the method is repeated two to three weeks after initially applying the at least 100 nsPEFs.

14. A method for inducing tumor regression in a tumor, the method comprising:

coating a tissue overlying the tumor with a composition that reduces flashover during pulse field application; and

applying at least 100 nsPEFs to said tumor, wherein each nsPEF has a pulse duration of at least about 10 nanoseconds and no more than about 1 microsecond and an electric field pulse strength of at least about 10 kV/cm and no more than about 350 kV/cm.

15. The method of claim 14 , wherein the tissue is one or a combination of any of the following: fat, bone, skin, muscle, cartilage.

16. The method of claim 14 , wherein the at least 100 nsPEFs are applied through a catheter electrode.

17. The method of claim 14 , wherein the electric field pulse strength is between about 20 kV/cm and about 45 kV/cm.

18. The method of claim 14 , wherein each nsPEF has a pulse duration of at least about 300 nanoseconds.

19. The method of claim 14 , wherein the tumor comprises cancer cells.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 22, 2024
From: EASTERN VIRGINIA MEDICAL SCHOOL
To: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 068364/0188 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2015
From: BEEBE, STEPHEN J.
To: EASTERN VIRGINIA MEDICAL SCHOOL
Reel/Frame 037392/0616 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2015
From: NUCCITELLI, RICHARD; SCHOENBACH, KARL H.
To: OLD DOMINION UNIVERSITY
Reel/Frame 037392/0642 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2015
From: OLD DOMINION UNIVERSITY
To: OLD DOMINION UNIVERSITY RESEARCH FOUNDATION
Reel/Frame 037392/0703 →
Continuity (3)
Continuation 12280280
Provisional Application 60776215 · Feb 24, 2006
Related Publication 20160015971A1 · Jan 21, 2016